Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongsheng Tu

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Statistics in Medicine|March 31, 2023
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomesYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
Pain|March 17, 2016
Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trialIan Gilron, Luis E Chaparro, Dongsheng Tu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
Menopause (New York, N.Y.)|May 21, 2020
Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trialHarriet Richardson, Vikki Ho, Romain Pasquet, et al.
Journal of the National Cancer Institute|September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerKim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
The New England Journal of Medicine|May 19, 2006
HER2 and responsiveness of breast cancer to adjuvant chemotherapyKathleen I Pritchard, Lois E Shepherd, Frances P O'Malley, et al.
Cancer|November 20, 2009
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials GroupScott A Laurie, Lillian L Siu, Eric Winquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical TrialsKarama Asleh, Dongsheng Tu, Dongxia Gao, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
Journal of Oncology Practice|July 16, 2019
Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?Timothy P Hanna, Paul Nguyen, Joseph Pater, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Statistics in Medicine|March 31, 2023
A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomesYangqing Deng, Dongsheng Tu, Chris J O'Callaghan, et al.
Pain|March 17, 2016
Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trialIan Gilron, Luis E Chaparro, Dongsheng Tu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 26, 2015
Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of lifeLori Brotto, Michael Brundage, Paul Hoskins, et al.
Menopause (New York, N.Y.)|May 21, 2020
Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trialHarriet Richardson, Vikki Ho, Romain Pasquet, et al.
Journal of the National Cancer Institute|September 8, 2005
A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancerKim N Chi, Elizabeth Eisenhauer, Ladan Fazli, et al.
The New England Journal of Medicine|May 19, 2006
HER2 and responsiveness of breast cancer to adjuvant chemotherapyKathleen I Pritchard, Lois E Shepherd, Frances P O'Malley, et al.
Cancer|November 20, 2009
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials GroupScott A Laurie, Lillian L Siu, Eric Winquist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical TrialsKarama Asleh, Dongsheng Tu, Dongxia Gao, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG)Helen J Mackay, Steven Gallinger, Ming S Tsao, et al.
Journal of Oncology Practice|July 16, 2019
Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses?Timothy P Hanna, Paul Nguyen, Joseph Pater, et al.
Pageof 20